Treatment Developed for Kidney Tumors
Posted on: Friday, 11 January 2008, 06:00 CST
U.S. and British researchers report they are finding success with a new treatment for kidney tumors in patients with the genetic disorder tuberous sclerosis.
A study, led by researchers at Cardiff University, Wales, examined a new treatment involving the drug Sirolimus, which was first identified from a soil sample taken from Easter Island. The drug has been shown to control the activity of the protein mTOR.
The protein, normally controlled by the TSC1 and TSC2 genes, becomes too active if the control genes fail -- leading to tuberous sclerosis, an inherited disease that causes tumors to grow in many of the organs of the body, the university said Thursday in a release.
Researchers found that after one year of treatment with Sirolimus, the diameters of kidney tumors in patients had shrunk by an average of 26 percent. A parallel study in the United States reported similar results, the university said.
The findings are published in The New England Journal of Medicine.
Source: United Press International
Related Articles
- Physicists and Clinicians at Leading Dutch Cancer Center Report Advances in Stereotactic Lung Tumor Treatments Using RapidArc Radiotherapy from Varian
- Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology
- High-Yielding Switchgrass the Focus of Ceres and University of Georgia Researchers
- Media General Completes Sale of Television Station to University of Georgia Research Foundation
- Flight Safety Announces Licensing of Technology From University of Tennessee Research Foundation
- Setting the Benchmark in Brain Tumor Treatment at The University of Texas M. D. Anderson Cancer Center
- Siemens and Haifu Collaborate to Advance Tumor Treatment; New MRI-Guided HIFU Improves Ultrasound Therapy
- MultiCell and Columbia University Begin Joint Research Program
- Construction of New University of Illinois Research Park Under Way
- University of Maryland Researchers Develop Anthrax Tracking Method
 |
 |
User Comments (0)
RSS Feeds